Your contention is that the RST patents won't cover the new FR technology. Majority of shareholders believe it does.
You aren't going to convince the shareholders otherwise. They are not patent lawyers or even chemists so most wouldn't have a clue. You will not find your answers here on this forum.
It may very well be you are right and Alexiums FR tech patents are only in application and not yet approved.
If so that is a risk, and its probably a risk you are unwilling to take. So move on to your next investment target.
Continuously challenging shareholders to find something that you yourself already searched for and came up empty is kind of a pointless exercise I would have thought? I can understand why your frustrated, but its a frustration of your own making.
AJX Price at posting:
52.0¢ Sentiment: Buy Disclosure: Held
